Boston Partners’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
VPM
RP
VCM
Boston Partners's ACLS Position: Q1 2026 in Review
Boston Partners reduced its Axcelis (ACLS) stake by 19% in Q1 2026, selling an estimated $7.28M and leaving 340,275 shares worth $31.8M. The position accounts for 0.03% of the portfolio, ranked #316.
Boston Partners first reported a position in ACLS in Q1 2020 and has held it in 21 quarters since. The position peaked at $44.9M in Q3 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.
- Boston Partners held 340,275 shares of Axcelis worth $31.8M as of Q1 2026.
- Boston Partners sold 82,160 Axcelis shares in Q1 2026, an estimated $7.28M.
- Axcelis made up 0.03% of Boston Partners's portfolio in Q1 2026, its #316 holding.
- Boston Partners first reported a position in Axcelis in Q1 2020 and has held it in 21 quarters since.
- Boston Partners's Axcelis position peaked at $44.9M in Q3 2025.
- 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.
Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.